TELA Bio, Inc.
TELA
$1.95
$0.010.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.78% | 18.56% | 29.34% | 31.64% | 40.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.78% | 18.56% | 29.34% | 31.64% | 40.03% |
| Cost of Revenue | 20.59% | 24.89% | 33.34% | 31.11% | 34.10% |
| Gross Profit | 9.36% | 15.75% | 27.61% | 31.87% | 42.79% |
| SG&A Expenses | -0.45% | 6.44% | 21.69% | 25.25% | 28.41% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -53.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.40% | 8.26% | 21.16% | 23.91% | 26.73% |
| Operating Income | 12.09% | 5.40% | -10.63% | -14.54% | -11.90% |
| Income Before Tax | -8.04% | 18.60% | 5.10% | 3.22% | 11.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.81% | 18.91% | 5.10% | 3.22% | 11.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.81% | 18.91% | 5.10% | 3.22% | 11.36% |
| EBIT | 12.09% | 5.40% | -10.63% | -14.54% | -11.90% |
| EBITDA | 12.80% | 5.97% | -10.72% | -14.79% | -13.35% |
| EPS Basic | 15.52% | 32.64% | 18.07% | 23.82% | 37.33% |
| Normalized Basic EPS | 28.59% | 17.54% | 3.09% | 10.12% | 23.31% |
| EPS Diluted | 15.52% | 32.75% | 18.19% | 23.93% | 37.40% |
| Normalized Diluted EPS | 28.59% | 17.54% | 3.09% | 10.12% | 23.31% |
| Average Basic Shares Outstanding | 39.17% | 24.75% | 14.37% | 25.37% | 38.95% |
| Average Diluted Shares Outstanding | 39.17% | 24.75% | 14.37% | 25.37% | 38.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |